Despite setbacks in DME, Adverum Biotechnologies said it will continue to develop ADVM-022 for wet AMD.
Victoria Johnson
Advertisement
Articles by Victoria Johnson
Advertisement
Latest Updated Articles
Serious adverse reaction halts gene therapy for diabetic macular edemaPublished: August 10th 2021 | Updated:
Advertisement
Advertisement
Trending on Modern Retina
1
Pipeline update: Catch up on recent updates in the retina pipeline
2
AAO 2025: The safety and efficacy of oral gildeuretinol in participants with intermediate-stage Stargardt disease
3
Study establishes reference data set for GA lesion progression
4
